|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240.15 USD | -2.82% |
|
-7.30% | -0.30% |
| 12/03 | Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing | MT |
| 11/03 | Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 15 | ||||||||
| 24 | ||||||||
| 31 | ||||||||
| 22 | ||||||||
| 33 | ||||||||
| 20 | ||||||||
| 28 | ||||||||
| 20 | ||||||||
| 17 | ||||||||
| 21 | ||||||||
| 21 | ||||||||
| 20 | ||||||||
| 19 | ||||||||
| 10 | ||||||||
| 16 | ||||||||
| 13 | ||||||||
| 14 | ||||||||
| 2 | ||||||||
| 11 | ||||||||
| 5 | ||||||||
| Average | 18 | |||||||
| Weighted average by Cap. | 24 |
- Stock Market
- Equities
- RMD Stock
- Sector ResMed, Inc.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















